IDIVAL Researchers Explore a New Drug Combination for Chronic Lymphocytic Leukaemia

by Instituto de Investigación Marqués de Valdecilla

The study has shown that Pevonedistat, a drug that blocks protein degradation, enhances the effect of Laduviglusib, an inhibitor previously shown to induce the death of leukaemic B lymphocytes. The co...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Ona Therapeutics Raises $86.6 Million Se...

by Ysios Capital

Proceeds to support clinical development of lead first-in-class progra...

Photos Stream